Holograms, Blockchain Tech can Curb Counterfeit Drugs, Says Mankind Pharma

One of India’s largest pharmaceutical companies, Mankind Pharma, endorses holograms and blockchain as significant tools to combat falsified medicines.

Endorsing the use of authentication technologies, Sheetal Arora, CEO of Mankind Pharma, said, ‘holograms and security labels embedded with advanced anticounterfeiting features (3D holographic images, unique patterns and microtext) are the most difficult to replicate. Similarly, blockchain improves traceability via end-to-end tracking of shipments.

Sheetal Arora, CEO, Mankind Pharma.

Curbing counterfeit drugs assumes importance when the Indian pharmaceutical industry, valued at $50 billion in 2023, is projected to reach $130 billion by 2030.

‘Although India is poised to become the world’s pharmacy, the country has also become a major hub for counterfeit drug production, as small operations can be set up easily with minimal infrastructure and overhead expenses,’ Mr Arora said.